Association of abdominal circumference with serum nitric oxide concentration in healthy population

  • Takaaki Kondo
  • Jun Ueyama
  • Ryota Imai
  • Koji Suzuki
  • Yoshinori Ito
Short Communication



We determined the relationship between abdominal circumference and the concentration of nitric oxide (NO), an endothelial cell product known to play an important role in the regulation of vascular tone and thrombocyte activations.


Subjects were 177 men and 339 women aged 40 or over who were free from a history of diabetes or malignancy. Analysis of covariance was applied to examine the gender-specific and smoking-status-specific associations of abdominal fat volume measured as waist circumference, waist-hip ratio, and waist-to-stature ratio, with serum NO level represented by the concentration of NO metabolites (NOx; nitrate plus nitrite).


Although men showed no statistical association between abdominal fat accumulation and NOx concentration, abdominal adiposity seemed to inversely affect the serum NOx concentration of never- and current-smoking women.


Our results suggest that a reduction in NO bioactivity occurs with abdominal fat accumulation in women. The underlying biological mechanism might involve adipocytokines secreted from visceral fat, but is yet to be elucidated.

Key words

metabolic syndrome nitric oxide adipocytokine endothelial dysfunction analysis of covariance 


  1. (1).
    Triggle CR, Howarth A, Cheng ZJ, Ding H. Twenty-five years since the discovery of endothelium-derived relaxing factor (EDRF): does a dysfunctional endothelium contribute to the development of type 2 diabetes? Can J Physiol Pharmacol. 2005;83:681–700.PubMedCrossRefGoogle Scholar
  2. (2).
    Blantz RC, Munger K. Role of nitric oxide in inflammatory conditions. Nephron. 2002;90:373–378.PubMedCrossRefGoogle Scholar
  3. (3).
    Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524–526.PubMedCrossRefGoogle Scholar
  4. (4).
    Forstermann U, Nakane M, Tracey WR, Pollock JS. Isoforms of nitric oxide synthase: functions in the cardiovascular system. Eur Heart J. 1993; 14 Suppl 1: 10–15.PubMedGoogle Scholar
  5. (5).
    Andrews HE, Bruckdorfer KR, Dunn RC, Jacobs M. Lowdensty lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta. Nature. 1987;327: 237–239.PubMedCrossRefGoogle Scholar
  6. (6).
    Luscher TF, Barton M. Biology of the endothelium. Clin Cardiol. 1997; 20:II-3–II-10.Google Scholar
  7. (7).
    Wenmalm A. Nitre oxide (NO) in the cardiovascular system: role in atherosclerosis and hypercholesterolemia. Blood Pressure. 1994;3:279–282.CrossRefGoogle Scholar
  8. (8).
    Wennmalm A. Endothelial nitric oxide and cardiovascular disease. J Intern Med. 1994; 235:317–327.PubMedCrossRefGoogle Scholar
  9. (9).
    Matsuzawa Y Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med. 2006;3:35–42.PubMedCrossRefGoogle Scholar
  10. (10).
    Kissebah AH. Intra-abdominal fat: is it a major factor in developing diabetes and coronary artery disease? Diabetes Res Clin Pract. 1996; Suppl:25–30.Google Scholar
  11. (11).
    Hartz AJ, Rupley DC, Rimm AA. The association of girth measurements with disease in 32,856 women. Am J Epidemiol. 1984;119:71–80.PubMedGoogle Scholar
  12. (12).
    Blair D, Habicht JP, Sims EA, Sylwester D, Abraham S. Evidence for an increased risk for hypertension with centrally located body fat and the effect of race and sex on this risk. Am J Epidemiol. 1984;119:526–540.PubMedGoogle Scholar
  13. (13).
    Folsom AR, Kaye SA, Sellers TA, Hong CP, Cerhan JR. Potter JD. et al. Body fat distribution and 5-year risk of death in older women. JAMA. 1993;269:483–487.PubMedCrossRefGoogle Scholar
  14. (14).
    Katzel LI, Busby-Whitehead MJ, Goldberg AP. Adverse effects of abdominal obesity on lipoprotein lipids in healthy older men. Exp Gerontol. 1993;28:411–420.PubMedCrossRefGoogle Scholar
  15. (15).
    Seidell JC. Obesity in Europe. Obes Res. 1995;3:89S-93S.PubMedGoogle Scholar
  16. (16).
    Han TS, van Leer EM, Seidell JC, Lean ME. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ. 1995;311:1401–1405.PubMedGoogle Scholar
  17. (17).
    Zhu S, Wang Z, Heshka S, Heo M, Faith MS, Heymsfield SB. Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. Am J Clin Nutr. 2002;76:743–749.PubMedGoogle Scholar
  18. (18).
    Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913 BMJ. 1984;288:1401–1404.PubMedGoogle Scholar
  19. (19).
    Funahashi T, Nakamura T, Shimomura I, Maeda K, Kuriyama H, Takahashi M, et al. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med. 1999;38:202–206.PubMedCrossRefGoogle Scholar
  20. (20).
    Yudkin JS, Eringa E, Stehouwer CD. “Vasocrine” signaling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet. 2005;365:1817–1820.PubMedCrossRefGoogle Scholar
  21. (21).
    Moshage H, Kok B, Huizenga JR, Jansen PL. Nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem. 1995;41:892–896.PubMedGoogle Scholar
  22. (22).
    Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Definition and the diagnostic standard for metabolic syndrome. Intern Med. 2005;94:794–809.Google Scholar
  23. (23).
    Shimokata H, Muller DC, Andres R. Studies in the distribution of body fat. III. Effects of cigarette smoking. JAMA. 1989;261:1169–1173.PubMedCrossRefGoogle Scholar
  24. (24).
    Busse R, Fleming I. Regulation and functional consequences of endothelial nitric oxide formation. Ann Med. 1995;27: 331–340.PubMedCrossRefGoogle Scholar
  25. (25).
    Verbeuren TJ, Jordaens FH, Zonnekeyn LL, Van Hove CE, Coene MC, Herman AG. Effect of hypercholesterolemia on vascular reactivity in the rabbit. I. Endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits. Circ Res. 1986;58:552–564.PubMedGoogle Scholar
  26. (26).
    Cui R, Iso H, Pi J, Kumagai Y, Yamagishi K, Tanigawa T, et al. Metabolic syndrome and urinary cGMP excretion in general population. Atherosclerosis. 2006 (in press).Google Scholar
  27. (27).
    Elherik K, Khan F, McLaren M, Kennedy G, Belch JJ. Circadian variation in vascular tone and endothelial cell function in normal males. Clin Sci. 2002;102:547–552.PubMedCrossRefGoogle Scholar
  28. (28).
    Raveendran M, Wang J, Senthil D, Wang J, Utama B, Shen Y, et al. Endogenous nitric oxide activation protects against eigarette smoking induced apoptosis in endothelial cells. FEBS Lett. 2005;579:733–740.PubMedCrossRefGoogle Scholar

Copyright information

© Japanese Society of Hygiene 2006

Authors and Affiliations

  • Takaaki Kondo
    • 1
  • Jun Ueyama
    • 1
  • Ryota Imai
    • 1
  • Koji Suzuki
    • 2
  • Yoshinori Ito
    • 3
  1. 1.Department of Medical TechnologyNagoya University School of Health SciencesNagoyaJapan
  2. 2.Department of Public Health Fujita Health University School of Health SciencesAichiJapan
  3. 3.Department of Preventive Medicine/Biostatistics and Medical Decision MakingNagoya University Graduate School of MedicineNagoyaJapan

Personalised recommendations